“Better preventing the spread of influenza – whether from a seasonal or pandemic strain – requires thoughtful investment in innovative new approaches, including non-pharmaceutical interventions,” said Coalition to Stop Flu Chairman and former Senate Majority Leader Tom Daschle. “We are delighted to welcome XCMR’s perspective to the Coalition.”
WASHINGTON, DC – July 30, 2024: The Coalition to Stop Flu is pleased to announce the addition of a new member, XCMR Inc., a medtech company that develops proprietary UV-C technology to prevent the transmission of infectious diseases. XCMR specializes in breakthrough biosecurity solutions that revolutionize respiratory protection paradigms. XCMR joins 24 other organizations leading the fight against seasonal and pandemic influenza.
XCMR’s patented maskless approach, powered by Near-field Infection Protection (NIP)™ technology, creates a personalized, “invisible bubble” of disinfected air, significantly reducing exposure to airborne pathogens like influenza in real time. This sustainable, groundbreaking approach extends to wearable, portable, and stationary devices, enhancing infection prevention and addressing antimicrobial resistance concerns. XCMR's next-generation implementation of UV-C demonstrates radical innovation as a proactive countermeasure against inhalational diseases.
“We believe that saving lives from influenza requires a multi-faceted approach that combines policy initiatives with cutting-edge technologies from across the healthcare spectrum,” said XCMR CEO Richard Rasansky. “XCMR is proud to join the Coalition to Stop Flu in advocating for much-needed research to develop and deploy next-generation solutions that complement other approaches, including pharmaceutical countermeasures. Together, we can create a world where the flu is no longer a threat.”
“Better preventing the spread of influenza – whether from a seasonal or pandemic strain – requires thoughtful investment in innovative new approaches, including non-pharmaceutical interventions,” said Coalition to Stop Flu Chairman and former Senate Majority Leader Tom Daschle. “We are delighted to welcome XCMR’s perspective to the Coalition.”
About the Coalition to Stop Flu
The Coalition to Stop Flu is a multi-sector advocacy coalition dedicated to ending deaths from seasonal and pandemic influenza. The Coalition’s federal policy agenda is aimed at saving lives, saving money, and protecting public health by enhancing the U.S. influenza ecosystem, including ensuring adequate funding for priority influenza programs. The Coalition’s members include Alvogen, the American Heart Association, the American Society for Microbiology, the Association of Immunization Managers, the Association of Public Health Laboratories, the Association of State and Territorial Health Officials, the Asthma and Allergy Foundation of America, CSL Seqirus, Eradivir, Families Fighting Flu, Genentech, GSK, the Global Health Investment Coalition, the Healthcare Distribution Alliance, IDBiologics, Immunize.org, the Infectious Diseases Society of America, Inovio Pharmaceuticals, the National Association of City and County Health Officials, the National Foundation for Infectious Diseases, Pfizer, Sanofi, Trust for America's Health, Vaccinate Your Family, and XCMR.
